Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SAU:4005 vs HCA, THC, DVA: Buyback Yield % Comparison
For the Medical Care Facilities subindustry, National Medical Care Co's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
National Medical Care Co Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, National Medical Care Co's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where National Medical Care Co's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
National Medical Care Co (SAU:4005) has a Buyback Yield % of 0.00 as of Aug. 18, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on National Medical Care Co and its competitors. Over the past decade, National Medical Care Co's Buyback Yield % has ranged from 0.46 to 0.46. According to the industry distribution chart, National Medical Care Co ranks #999999 out of 262 companies in the Healthcare Providers & Services industry.
Is National Medical Care Co's Buyback Yield % too high?
National Medical Care Co's current Buyback Yield % is 0.00. Over the past 10 years, this metric has ranged from a low of 0.46 to a high of 0.46. Based on the distribution chart, National Medical Care Co ranks #999999 out of 262 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, National Medical Care Co has a GF Score™ of 92/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does National Medical Care Co's Buyback Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, National Medical Care Co ranks #999999 out of 262 companies for Buyback Yield %. This places National Medical Care Co in the lower half of its industry. Historically, National Medical Care Co's own Buyback Yield % has ranged from 0.46 to 0.46 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on National Medical Care Co and its competitors. National Medical Care Co's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is National Medical Care Co stock overvalued right now?
Based on GuruFocus' analysis, National Medical Care Co (SAU:4005) is currently considered Possible Value Trap. The stock's GF Value™ is ﷼208.24, compared to a current price of ﷼121.70 — trading 41.6% below its estimated fair value. The current Buyback Yield % is 0.00. National Medical Care Co's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For National Medical Care Co (SAU:4005), the current Buyback Yield % is 0.00 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is National Medical Care Co (SAU:4005) Overvalued in 2026?
Based on GuruFocus' analysis, National Medical Care Co stock appears to be undervalued.
The current stock price of ﷼121.70 is trading 41.6% below its estimated GF Value™ of ﷼208.24.
GuruFocus considers National Medical Care Co to be Possible Value Trap.
Key valuation signals for SAU:4005:
Buyback Yield %: 0.00
GF Value™: ﷼208.24 vs. price of ﷼121.70 (41.6% below fair value)
No single metric tells the full story. See the SAU:4005 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
National Medical Care Co is engaged in the business to establish, own, equip, manage, maintain, and operate healthcare facilities and provide home health care services. The company trades medicines, medical equipment, and supplies in wholesale and retail trade. Geographically, all operations are conducted in the Kingdom of Saudi Arabia. The company generates revenue through the Rendering of clinical services, and the Sale of pharmaceuticals.
92GF Score
Get the complete analysis for SAU:4005
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4005 has been successfully added to your 
